Speech-Language Pathologists in Shillington, PA Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Deborah Henne, M.A., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 E. Philadelphia Ave., Shillington, PA 19607 Phone: 610-796-7032

Marybeth Sterner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 S Waverly St, Shillington, PA 19607 Phone: 610-775-1461

Emily Gentile, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 E Philadelphia Ave, Shillington, PA 19606 Phone: 610-777-7841

Denise M Sands, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Philadelphia Ave, Shillington, PA 19607 Phone: 610-796-7032

Jane Licatovich, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Philadelphia Ave, Shillington, PA 19607 Phone: 610-796-7022

News Archive

University of Missouri researchers identify key protein component that causes cystic fibrosis

Nearly 70,000 people worldwide are living with cystic fibrosis, a life-threatening genetic disease. There currently is no cure for the condition, but researchers from the University of Missouri have identified a key component in the protein that causes the disease. It is a finding that may lay the foundation for the development of new medications and improved therapies.

Comprehensive review article on baroreflex sensitivity after SCI

Spinal cord injury (SCI) can disrupt the body's sensitive signaling mechanisms that control blood pressure, breathing, and oxygen delivery to the heart and other organs during changes in body position. Cardiovascular (CV) disease is a leading cause of illness and death following SCI, and changes in baroreflex sensitivity-the body's ability to detect and respond to changes in blood pressure-may be predictive of a CV event.

NVHR releases statement on New York Times article 'Hope against Hepatitis C'

In response to today's New York Times article, "Hope against Hepatitis C," Andrew Muir, M.D., M.H.S., Director, Gastroenterology/Hepatology Research, Duke Clinical Research Institute and Steering Committee Member of the National Viral Hepatitis Roundtable (NVHR) released the following statement:

Helicos BioSciences to develop, market MDx tests that utilize HeliScope Single Molecule Sequencer

Helicos BioSciences Corporation announced today that it is in the early stages of validating molecular diagnostic (MDx) tests that utilize its HeliScope® Single Molecule Sequencer. The HeliScope Sequencer's ability to sequence single molecules of natural, unamplified DNA or RNA simplifies the diagnostic testing workflow obviating the need for the amplification steps utilized by most genetic analysis methods.

Read more Medical News

› Verified 3 days ago